Gemzar®(Ci) and epirubicin (E) in patients (pts) with metastatic breast cancer(MBC):: Final results of a phase I dose finding study

被引：0
|
作者：
Fumoleau, P
Viens, P
Dieras, V
Pujade-Lauraine, E
Espie, M
Kayitalire, L
Rongier, AM
Pouillart, P
机构：
[1] Ctr Rene Gauducheau, F-44035 Nantes, France
[2] Inst J Paoli I Calmettes, F-13009 Marseille, France
[3] Inst Curie, Paris, France
[4] Hop St Louis, Paris, France
[5] Hotel Dieu, Paris, France
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1173
引用
收藏
页码：S292 / S292
页数：1
相关论文
共 50 条
  • [1] Final results of gemcitabine (G) and epirubicin (E) phase II trial in metastatic breast cancer (MBC) patients (pts).
    Fumoleau, P
    Viens, P
    Dieras, V
    Pujade-Lauraine, E
    Serin, D
    Petit, T
    Espie, M
    Kayitalire, L
    Robert, C
    Pouillart, P
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S90 - S90
  • [2] Phase I evaluation of lapatinib (L) and epirubicin (E) in patients (pts) with anthracycline (anth)-naive metastatic breast cancer (MBC)
    O'Connor, R. A.
    Kennedy, M. J.
    McDermott, S. R.
    Tryfanopoulos, D.
    McCreery, C.
    Collins, D.
    Martynyuk, O.
    Gethins, R.
    Moulton, B.
    Crown, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [3] Docetaxel with epirubicin as first line chemotherapy in metastatic breast cancer (MBC).: Final results of a Phase II study
    Morales, S
    Lorenzo, A
    Ramos, M
    Ballesteros, P
    Méndez, M
    Almanza, C
    Moreno-Nogueira, J
    Casal, J
    Castellanos, J
    Lizón, J
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S68 - S68
  • [4] TAXOL(R) (paclitaxel) and FARMORUBICIN(R) (epirubicin) in metastatic breast cancer (MBC): Preliminary results of a phase I study
    Spielmann, M
    Catimel, G
    Kayitalire, L
    Pouillart, P
    Dumortier, A
    Graffand, N
    PellaeCosset, B
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 370 - 370
  • [5] Taxol(TM) (Paclitaxel), epirubicin and cyclophosphamide (TEC) in the treatment of metastatic breast cancer (MBC): results of a phase I study
    Nabholtz, JM
    Khoo, K
    Mackey, JR
    Smylie, M
    AlTwegieri, T
    Dudgeon, D
    Keller, O
    Foerster, O
    Olweny, C
    Shore, T
    Sansregret, E
    Stiles, E
    Dulude, H
    Gallant, G
    Brown, B
    BREAST, 1997, 6 (05): : 320 - 320
  • [6] Combination chemotherapy with paclitaxel (T) and epirubicin (E) for metastatic breast cancer (MBC): A phase I-II study
    Durando, A
    Alabiso, O
    Bellino, R
    Genta, F
    Katsaros, D
    Malossi, A
    Aidala, S
    Mussa, A
    Massobrio, M
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S12 - S13
  • [7] Taxol(TM) (Paclitaxel), Epirubicin and Cyclophosphamide (TEC) in the treatment of metastatic breast cancer (MBC): Results of a phase I study
    Nabholtz, JM
    Khoo, K
    Mackey, JR
    Smylie, M
    AlTweigeri, T
    Dudgeon, D
    Keller, O
    Foerster, O
    Olweny, C
    Shore, T
    Sansregret, E
    Stiles, E
    Dulude, H
    Gallant, G
    Brown, B
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 678 - 678
  • [8] Gemcitabine plus epirubicin plus taxol (GET) in metastatic breast cancer (MBC) patients (pts): A multicenter phase II study.
    Donati, S
    Gennari, A
    Conte, PF
    Cetto, GL
    Molino, A
    Crino, L
    Mazzoni, F
    Galligioni, E
    Mansutti, M
    ANNALS OF ONCOLOGY, 2000, 11 : 50 - 50
  • [9] Vinorelbine and epirubicin in metastatic breast cancer. A dose finding study
    Blomqvist, C
    Hietanen, P
    Teerenhovi, L
    Rissanen, P
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (13-14) : 2406 - 2408
  • [10] Final results of a phase II clinical and pharmacokinetical trial with oral idarubicin (IDA) in elderly patients (pts) with metastatic breast cancer (MBC).
    Crivellari, D
    Lombardi, D
    Sorio, R
    La Mura, N
    Massacesi, C
    Lucenti, A
    Ferro, A
    Veronesi, A
    Corona, G
    Toffoli, G
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 59S - 59S
12345